Ribostamycin sulfate structure
|
Common Name | Ribostamycin sulfate | ||
---|---|---|---|---|
CAS Number | 53797-35-6 | Molecular Weight | 552.551 | |
Density | 1.6g/cm3 | Boiling Point | 907.6ºC at 760 mmHg | |
Molecular Formula | C17H36N4O14S | Melting Point | 175-180ºC | |
MSDS | Chinese USA | Flash Point | 502.7ºC | |
Symbol |
GHS07, GHS08 |
Signal Word | Danger |
Use of Ribostamycin sulfateRibostamycin is a broad-spectrum antimicrobial, inhibits bacterial protein synthesis at the level of 30S and 50S ribosomal subunit binding, also inhibits the chaperone activity of protein disulfide isomerase (PDI), used in pharmacokinetic and nephrotoxicity studies |
Name | ribostamycin sulfate |
---|---|
Synonym | More Synonyms |
Description | Ribostamycin is a broad-spectrum antimicrobial, inhibits bacterial protein synthesis at the level of 30S and 50S ribosomal subunit binding, also inhibits the chaperone activity of protein disulfide isomerase (PDI), used in pharmacokinetic and nephrotoxicity studies |
---|---|
Related Catalog |
Density | 1.6g/cm3 |
---|---|
Boiling Point | 907.6ºC at 760 mmHg |
Melting Point | 175-180ºC |
Molecular Formula | C17H36N4O14S |
Molecular Weight | 552.551 |
Flash Point | 502.7ºC |
Exact Mass | 552.194885 |
PSA | 345.36000 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Symbol |
GHS07, GHS08 |
---|---|
Signal Word | Danger |
Hazard Statements | H312-H332-H360 |
Precautionary Statements | P201-P280-P308 + P313 |
Personal Protective Equipment | Eyeshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
Hazard Codes | T,Xi |
Risk Phrases | R61 |
Safety Phrases | S22-S45-S53-S36-S37-S39 |
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
RTECS | WK2300000 |
DrugBank 3.0: a comprehensive resource for 'omics' research on drugs.
Nucleic Acids Res. 39 , D1035-41., (2011) DrugBank (http://www.drugbank.ca) is a richly annotated database of drug and drug target information. It contains extensive data on the nomenclature, ontology, chemistry, structure, function, action, ... |
|
Comparative nephrotoxicity of ribostamycin and gentamicin in rats evaluated by urinalysis.
Polym. Degrad. Stab. 15 , 273-289, (1989) The nephrotoxicity of ribostamycin and gentamicin was compared by urinalysis using 18 parameters. When a dose of 40 mg/kg per day was administered intramuscularly to Fischer rats for 14 days, ribostam... |
|
Pharmacokinetics of ribostamycin in paediatric patients.
Clin. Pharmacokinet. 22 , 144-151, (1992) In the present study, ribostamycin concentrations in serum were measured by microbiological assay in 20 paediatric patients aged 3 months to 11 years after intramuscular ribostamycin 10, 15 and 20 mg/... |
α-D-Glucopyranoside, (1R,2R,3S,4R,6S)-4,6-diamino-3-hydroxy-2-(β-D-ribofuranosyloxy)cyclohexyl 2,6-diamino-2,6-dideoxy-, sulfate (1:1) (salt) |
Riboflavine Sulfate |
Ribostamycin sulfate salt |
EINECS 258-783-1 |
MFCD00057496 |
Vistamycin |
(1R,2R,3S,4R,6S)-4,6-Diamino-3-hydroxy-2-(β-D-ribofuranosyloxy)cyclohexyl 2,6-diamino-2,6-dideoxy-α-D-glucopyranoside sulfate (1:1) |
Ribostamycin sulfate |
Ribostamycin (sulfate) |